83 indexable Life Sciences Platforms and Tools companies headquartered in Karnataka, India, ranked by total equity funding and recent funding momentum. Combined disclosed equity funding of $137.1M across 24 funded companies.
| # | Company | Funding | Valuation | Stage | Latest round | Employees | Founded | Momentum |
|---|---|---|---|---|---|---|---|---|
| 1 |
Pandorum
Developer of regenerative medicine and 3D tissues |
$27.1M | $48.3M as of 2024 |
Series B | Series B Mar 2026 | 26 | 2011 | ↑ Active |
| 2 |
SigTuple
Provider of AI-powered diagnostic solutions for laboratories and hospitals |
$54.7M | $29.1M as of 2024 |
Series C | Series C Aug 2024 | 95 | 2015 | ↑ Active |
| 3 |
Morphle
Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions. |
$150K | — | Series A | Series A Nov 2025 | 52 | 2017 | ↑ Active |
| 4 |
Mestastop
Developer of cell-based functional assays for cancer metastasis focused drug discovery and predictive diagnostics |
$1.3M | $4.8M as of 2024 |
Seed | Grant (prize money) Nov 2024 | 12 | 2018 | ↑ Active |
| 5 |
Cambrian Bioworks
Manufacturer of PCR plate seal, sample preparation, and extraction kits |
$1.4M | — | Seed | Seed Aug 2024 | 30 | 2020 | ↑ Active |
| 6 |
Leucine Rich Bio
Provider of the genomics-based platform to analyze microbiome |
$424.6K | $4M as of 2023 |
Seed | Angel Nov 2024 | 13 | 2014 | ↑ Active |
| 7 |
BlackFrog Technologies
Provider of a portable temperature-regulated carrier for biologicals cold‑chain delivery solutions |
$308.4K | $2.1M as of 2022 |
Seed | Seed Jan 2025 | 26 | 2015 | ↑ Active |
| 8 |
Strand Life Sciences
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery |
$36.9M | — | Acquired | Series C Feb 2018 | 522 | 2000 | — |
| 9 |
BioDimension
Developer of advanced human tissue models and patient-derived organoids for pharmaceutical research |
$143.9K | — | Seed | Seed Oct 2024 | — | 2021 | ↑ Active |
| 10 |
Richcore Lifesciences
Developer of enzymes for industrial solutions |
$9.9M | $16.6M as of 2015 |
Acquired | Series A Jun 2016 | 402 | 2001 | — |
| 11 |
Shilps Sciences
Developer of microfluidic devices for imaging and characterization at the nano and micro scale |
$1.7M | $3.2M as of 2020 |
Seed | Seed Oct 2020 | 12 | 2013 | — |
| 12 |
VNIR
Developer of infra red fluorescence based diagnostic molecules |
$724.5K | $4.3M as of 2021 |
Seed | Angel Nov 2021 | — | 2017 | — |
| 13 |
Ameliorate Biotech
Developer of recombinant therapeutic proteins and diagnostic kits |
$549.3K | $1.7M as of 2021 |
Seed | Seed Mar 2021 | — | 2015 | — |
| 14 |
Dhiti Omics
Provides precision molecular diagnostic services |
$278.4K | $1.7M as of 2022 |
Seed | Angel Oct 2022 | — | 2014 | — |
| 15 |
Clevergene
Provides genomic-based bioinformatics solutions for research and translational sciences |
$632.8K | $4.1M as of 2020 |
Seed | Seed Jan 2020 | 2 | 2013 | — |
| 16 |
QTLomics
Developer of agri-genomics based research and development |
$212K | $1.1M as of 2016 |
Seed | Grant (prize money) May 2017 | 13 | 2013 | — |
| 17 |
Genotypic
Provider of genomics and bioinformatics services |
$171.2K | $381.3K as of 2006 |
Seed | Angel Mar 2006 | 87 | 1998 | — |
| 18 |
International Stemcell Services
Provides storage of human adult stem cells |
$84.2K | — | Seed | Seed May 2018 | — | 2008 | — |
| 19 |
Next Big Innovation Labs
Developer of 3D bioprinters for tissue engineering |
$77.3K | — | Seed | Seed Jan 2019 | — | 2016 | — |
| 20 |
Pentavalent
Provider of vaccines and research services |
$40.8K | $809.6K as of 2020 |
Seed | Seed Oct 2020 | — | 2015 | — |
| 21 |
BendFlex
Medical device to improve the success rate of IVF process |
$76.1K | — | Funding Raised | Grant (prize money) May 2017 | — | 2015 | — |
| 22 |
Lablinks Biotech
Developer of bioprotective equipment for agriculture and pharma industries |
$75.2K | $601.5K as of 2014 |
Early Stage | Jun 2014 | — | 1989 | — |
| 23 |
Viravecs Labs
Provider of gene therapy and gene editing services |
$61.4K | — | Deadpooled | Grant (prize money) May 2017 | — | 2014 | — |
| 24 |
Labland Biotechs
Provider of tissue culture and plantlets |
$32.9K | $964.2K as of 2016 |
Seed | Angel Oct 2016 | 2 | 1994 | — |
| 25 |
BioCompute
Develops sustainable DNA-based data storage solutions |
— | — | Seed | Seed 2024 | — | 2024 | — |
| 26 |
Kcat
Provider of solution and services for protein optimisation and engineering |
— | — | Seed | Seed Mar 2023 | 32 | 2018 | — |
| 27 |
Azooka Life Sciences
Nucleic acid fluorescent strains for molecular diagnostics and other genomic applications |
— | — | Seed | Seed Oct 2021 | — | 2015 | — |
| 28 |
Rapiddx Technologies
Developer of antimicrobial susceptibility test platform |
— | — | Funding Raised | Grant (prize money) May 2021 | — | 2019 | — |
| 29 |
Farm Gulp
Manufacturer of different biochemicals |
— | — | Funding Raised | Grant (prize money) Aug 2019 | — | 2018 | — |
| 30 |
AmraysBio
Provider of recombinant proteins |
— | — | Deadpooled | Grant (prize money) 2019 | — | 2019 | — |
| 31 |
Cellagility
Developer of induced pluripotent stem cells for drug discovery |
— | — | Funding Raised | Grant (prize money) 2019 | — | 2017 | — |
| 32 |
Skanda Life Sciences
Company offering drug discovery and preclinical development services |
— | — | Funding Raised | Grant (prize money) 2019 | — | 2012 | — |
| 33 |
GaloreTx
Manufacturer of peptide and peptide-based therapies |
— | — | Funding Raised | Grant (prize money) Sep 2018 | 21 | 2018 | — |
| 34 |
Kyntox Biotech
Provider of a wide range of research services for the life sciences industry |
— | — | Funding Raised | Sep 2018 | — | 2018 | — |
| 35 |
Denovo Biolabs
Developer of assays for application in laboratory research |
— | — | Funding Raised | Grant (prize money) Aug 2017 | — | 2013 | — |
| 36 |
Tintorang
Fluorescent stain for application in biological sciences and genomics |
— | — | Seed | Seed Mar 2016 | — | 2015 | — |
| 37 |
BiOZEEN
Provider of customized bioprocess equipment and automation solutions for the biopharmaceutical industry |
— | — | Funding Raised | Venture Debt 2008 | 194 | 2005 | — |
| 38 |
64 Codon
Provider of open network biobanking services for research purposes |
— | — | Funding Raised | — | — | 2016 | — |
| 39 |
Abexome Bioscience
CRO focusing on developing antibodies and ELISA assays for the biopharmaceutical industry and research labs |
— | — | Deadpooled | — | — | 2007 | — |
| 40 |
Aigener
Provider of genome sequencing and data analysis services |
— | — | Unfunded | — | — | 2021 | — |
| 41 |
Alantis Sciences
Provider of molecular biology and microbiology research services |
— | — | Funding Raised | — | — | 2020 | — |
| 42 |
Bangalore Genie
Develops products for proteomics and genomics research |
— | — | Deadpooled | — | — | 1970 | — |
| 43 |
Barcode Biosciences
Provider of genomic sequencing services |
— | — | Unfunded | — | — | 2018 | — |
| 44 |
Bigtec Labs
Developer of point-of-care solutions for nucleic acid amplification tests |
— | — | Funding Raised | — | 633 | 2000 | — |
| 45 |
BioCOS Life Sciences
Data Analysis for Lifescience Research |
— | — | Deadpooled | — | — | 2008 | — |
| 46 |
Biokart
Provider of genomic-based sequencing services |
— | — | Unfunded | — | — | 2011 | — |
| 47 |
Bionivid
Provider of sequencing and microarray data analytics solutions for genomics research |
— | — | Funding Raised | — | — | 2011 | — |
| 48 |
Biopol Biosciences
Operator of microbial fermentation technology |
— | — | Funding Raised | — | — | 2020 | — |
| 49 |
Cell Forge
Manufacturer of recombinant proteins for biopharma, diagnostics, food technology, and cosmetics |
— | — | Unfunded | — | — | 2025 | — |
| 50 |
Cellsion Technologies
Provider of engineered human tissues and organoids for research applications |
— | — | Funding Raised | — | — | 2022 | — |
Developer of regenerative medicine and 3D tissues. It has developed a working 3D tissue through 3D printing and fabrication techniques. The products include bioengineered cornea which is a hydrogel formulation used for blindness, 3D hepatocyte spheroids for drug discovery and liver therapies, and exosome cell-free therapy for lung regeneration.
Provider of AI-powered diagnostic solutions for laboratories and hospitals. It is a healthcare technology company that leverages artificial intelligence, robotics, and cloud computing to develop intelligent screening solutions for medical diagnostics. The products are designed to automate microscopy and enable AI-assisted digital analysis of visual medical data.
{}
Developer of cell-based functional assays for cancer metastasis focused drug discovery and predictive diagnostics. It offers platform which include Metaassay, Metvivo, and Metscan for metastasis with a combination of in vitro tests for scoring compounds as per their inhibitory potential of metastasis and then progressing the lead molecules in genetically engineered xenograft models.
Manufacturer of PCR plate seal, sample preparation, and extraction kits. It builds products and applications for the Diagnostics and life sciences sectors. It products are used across a wide variety of diagnostics and life sciences applications.
Provider of the genomics-based platform to analyze microbiome. The Bugspeaks platform is used to analyze gut microbial sequencing data to provide personalized dietary and supplements recommendations. Other platforms are Metarich that is for cloud-based microbiome analysis, Rychbiome develops probiotics, prebiotics & synbiotics based on the microbiome. The company is also developing two programs LRB120305 is formulati
Provider of a portable temperature-regulated carrier for biologicals cold‑chain delivery solutions. It offers a portable medical-grade refrigeration system for the effective transportation of vaccines, insulin, breast-milk, blood-serums, medications and specimens with minimal freeze-thaw cycles and can maintain 2–8 °C for 10–20 h depending on conditions. It uses thermoelectric cooling with PID control and
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery. The company provides sequence-based diagnostics and clinical genomic data interpretation services to healthcare establishments. Also, offers solutions for integrated omics analysis, image management, systems biology modeling, and molecular modeling.
Developer of advanced human tissue models and patient-derived organoids for pharmaceutical research. It develops proprietary biofabricated human tissue modelsincluding reconstructed human epidermis and full-thickness skinand patient-derived organoids that mimic human biology than conventional 2D cell cultures or animal models. These platforms enable cosmetic, personal care, pharmaceutical, nutraceutical and chemical
Richcoreindia develops enzymes for industrial solutions. The company is developing enzyme-based products for industries of sugar, alcohol, paper, pulp, textiles, refineries and petrochemicals. The firm’s key focus areas are novel enzyme applications for the energy, food and water industries.
Developer of microfluidic devices for imaging and characterization at the nano and micro scale. It offers Droplet Microfluidic Platform that combines advanced microscopy with microfluidic nano-bio reactors which accelerate single-gene cell applications, and perform time-lapse microscopy analysis of cells.
VNIR develops infrared fluorescence-based imaging and diagnostic molecules. The company claims that fluorescence molecules/probes are used for live-cell imaging and early-stage detection of Alzheimer's, malaria, kidney failure at an early stage are in development. The probes absorb green light and emit red light and used in ROS staining, mitochondria staining, and plant protoplast staining.
BIRAC
Startup Karnataka
AIC-JITF
HCG
Rankings are computed by Radar (Fliar BI) from the Radar company master and are updated periodically. Funding and momentum scores use disclosed equity-funding data only. Figures may lag private rounds. Last updated 2026-06-22.